Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Monoclonal antibodies to interleukin 35 and methods of use thereof to inhibit regulatory T cell function

Monoclonal antibodies to interleukin 35 and methods of use thereof to inhibit regulatory T cell function

US Patent 9518113 · Granted Dec 13, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of increasing T cell immune response in the treatment of cancer2021
Methods of increasing T cell immune response in the treatment of cancer2021
Methods for treatment comprising an antibody that binds CD223 protein2020
Methods for treatment comprising an antibody that binds CD223 protein2020
Polynucleotide encoding IL-35 receptor2019
Therapies based on control of regulatory T cell stability and function via a neu2017
T effector cells modulated via interleukin 35 and methods of culturing same2015
T effector cells modulated via interleukin 35 and methods of culturing same2015
T effector cells modulated via interleukin 35 and methods of culturing same2015
T effector cells modulated via interleukin 35 and methods of culturing same2015
Method for treating cancer with an antibody to CD223 protein2015
Method for treating cancer with an antibody to CD223 protein2015